News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HANHAM ANN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/15/2022 |
4
| HANHAM ANN (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 8,000 options to buy
@ $0.86, valued at
$6.9k
|
|
| 06/22/2022 |
4
| HANHAM ANN (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 10,000 options to buy
@ $1.78, valued at
$17.8k
|
|
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| HANHAM ANN (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 10,000 options to buy
@ $7.51, valued at
$75.1k
|
|
| 03/31/2021 |
4/A
| HANHAM ANN (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 55,000 options to buy
@ $0.73, valued at
$40.2k
|
|
| 12/23/2020 |
4
| HANHAM ANN (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Bought 3,200 shares
@ $6.25, valued at
$20k
Granted 1,600 warrants
@ $7.33, valued at
$11.7k
Granted 1,600 warrants
@ $8.25, valued at
$13.2k
|
|
| 08/21/2020 |
4
| HANHAM ANN (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 60,000 options to buy
@ $0.46, valued at
$27.6k
|
|
| 07/08/2020 |
4
| HANHAM ANN (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 45,000 options to buy
@ $0.73, valued at
$32.9k
|
|
| 08/16/2019 |
4
| HANHAM ANN (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 10,000 options to buy
@ $1.04, valued at
$10.4k
|
|
| 06/20/2019 |
4
| HANHAM ANN (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 45,000 options to buy
@ $1.29, valued at
$58.1k
|
|
| 01/04/2019 |
4
| HANHAM ANN (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 22,500 options to buy
@ $0.5441, valued at
$12.2k
|
|
| 09/12/2018 |
4
| HANHAM ANN (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 2,304 shares
@ $4.34, valued at
$10k
|
|
| 08/17/2018 |
4
| HANHAM ANN (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 10,000 options to buy
@ $3.31, valued at
$33.1k
|
|
| 01/04/2018 |
4
| HANHAM ANN (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 19,989 options to buy
@ $2.28, valued at
$45.6k
|
|
| 08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/29/2016 |
4
| HANHAM ANN (Director) has filed a Form 4 on HTG MOLECULAR DIAGNOSTICS, INC|
Txns:
| Granted 10,000 options to buy
@ $2.61, valued at
$26.1k
|
|
| 06/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2013 |
4
| HANHAM ANN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 14,000 options to buy
@ $12.94, valued at
$181.2k
|
|
| 05/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2012 |
4
| HANHAM ANN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 9,417 shares
@ $6.6029, valued at
$62.2k
Sold 290,719 shares
@ $6.6033, valued at
$1.9M
Sold 783 shares
@ $6.6029, valued at
$5.2k
Sold 24,181 shares
@ $6.6033, valued at
$159.7k
|
|
| 06/04/2012 |
4/A
| HANHAM ANN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 25,758 shares
@ $6.6506, valued at
$171.3k
Sold 2,142 shares
@ $6.6506, valued at
$14.2k
|
|
| 06/04/2012 |
4
| HANHAM ANN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 10,000 options to buy
@ $6.43, valued at
$64.3k
|
|
| 05/18/2012 |
4
| HANHAM ANN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 25,758 shares
@ $6.6506, valued at
$171.3k
Sold 2,142 shares
@ $6.6506, valued at
$14.2k
|
|
| 05/16/2012 |
4
| HANHAM ANN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 98,785 shares
@ $6.9354, valued at
$685.1k
Sold 36,929 shares
@ $6.6787, valued at
$246.6k
Sold 8,215 shares
@ $6.9354, valued at
$57k
Sold 3,071 shares
@ $6.6787, valued at
$20.5k
|
|
| 05/31/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2011 |
4/A
| HANHAM ANN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 15,706 options to buy
@ $0 |
|
| 02/11/2011 |
4
| HANHAM ANN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Converted 768,795 shares
@ $0
Converted 63,940 shares
@ $0
Converted 341,194 convertible preferred
@ $0
Converted 427,601 convertible preferred
@ $0
Converted 28,377 convertible preferred
@ $0
Converted 35,563 convertible preferred
@ $0
Granted 15,706 options to buy
@ $7.23, valued at
$113.6k
|
|
| 02/08/2011 |
4
| HANHAM ANN (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 461,608 shares
@ $6, valued at
$2.8M
Granted 38,392 shares
@ $6, valued at
$230.4k
|
|
| 02/04/2011 |
3
| HANHAM ANN (Director) has filed a Form 3 on ENDOCYTE INC |
|
|